Watch Demo

Newborn Screening Market Research Report by Product, Test Type, Technology, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

Newborn Screening Market Research Report by Product, Test Type, Technology, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030
  • Publish Date:January 2023

  • Number of Pages:137

  • Report ID:6402306

  • Format:PDF

  • Publisher:360iResearch

$ 3949

Summary

Newborn Screening Market Research Report by Product (Consumables and Instrument), Test Type, Technology, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

The United States Newborn Screening Market is projected to grow with a significant CAGR in the forecast period. Economic development and substantial infrastructure development have constituted regional revenue generation. Further, the patterns associated with domestic production, import and export, and consumption have helped market participants to analyze and capitalize on potential opportunities. Besides, the qualitative and quantitative parameters provided in the report with detailed analysis highlights the driving and restraining factors of the United States Newborn Screening Market.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the United States Newborn Screening Market.

Cumulative Impact of Russia-Ukraine Conflict:

We continuously monitor and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the United States Newborn Screening Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The United States Newborn Screening Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the United States Newborn Screening Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group’s economies and geographies can help gain business acumen for better strategic decision-making. Our market coverage across different industry verticals reveals the hidden truth about the players’ strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for your market plan. This research report categorizes the United States Newborn Screening Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Product, the market is studied across Consumables and Instrument.

Based on Test Type, the market is studied across CCHD, Dried Blood Spot, and Hearing Screening.

Based on Technology, the market is studied across Enzyme Assay, Immunoassay, Molecular, Pulse Oximetry, and Tandem Mass Spectrometry.

Based on End User, the market is studied across Clinical Laboratories and Hospitals.

Based on State, the market is studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the United States Newborn Screening Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The United States Newborn Screening Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The United States Newborn Screening Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The United States Newborn Screening Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the United States Newborn Screening Market, including Baebies, Inc., Bio-Rad Laboratories, Covidien PLC, Danaher Corporation, Demant A/S, GE Healthcare, Medtronic Plc, MP BIOMEDICALS, Natus Medical Incorporated, PerkinElmer, Inc., Thermo Fisher Scientific Inc., and Trivitron Healthcare.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the United States Newborn Screening Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the United States Newborn Screening Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the United States Newborn Screening Market?
4. What is the competitive strategic window for opportunities in the United States Newborn Screening Market?
5. What are the technology trends and regulatory frameworks in the United States Newborn Screening Market?
6. What is the market share of the leading vendors in the United States Newborn Screening Market?
7. What modes and strategic moves are considered suitable for entering the United States Newborn Screening Market?

Table of contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising prevalence of newborn disorders in the U.S.
5.1.1.2. Availability of newborn screening programs
5.1.2. Restraints
5.1.2.1. Lack of skilled care and screening of the babies
5.1.3. Opportunities
5.1.3.1. Favorable reimbursement policies in the United States
5.1.3.2. Technological advancements in the newborn screening
5.1.4. Challenges
5.1.4.1. Availability of refurbished products
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter's Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization

6. Newborn Screening Market, by Product
6.1. Introduction
6.2. Consumables
6.3. Instrument

7. Newborn Screening Market, by Test Type
7.1. Introduction
7.2. CCHD
7.3. Dried Blood Spot
7.4. Hearing Screening

8. Newborn Screening Market, by Technology
8.1. Introduction
8.2. Enzyme Assay
8.3. Immunoassay
8.4. Molecular
8.5. Pulse Oximetry
8.6. Tandem Mass Spectrometry

9. Newborn Screening Market, by End User
9.1. Introduction
9.2. Clinical Laboratories
9.3. Hospitals

10. California Newborn Screening Market
10.1. Introduction

11. Florida Newborn Screening Market
11.1. Introduction

12. Illinois Newborn Screening Market
12.1. Introduction

13. New York Newborn Screening Market
13.1. Introduction

14. Ohio Newborn Screening Market
14.1. Introduction

15. Pennsylvania Newborn Screening Market
15.1. Introduction

16. Texas Newborn Screening Market
16.1. Introduction

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis, By Key Player
17.3. Market Share Analysis, By Key Player
17.4. Product Portfolio Analysis, By Key Player
17.5. Competitive Scenario
17.5.1. Merger & Acquisition
17.5.2. Agreement, Collaboration, & Partnership
17.5.3. New Product Launch & Enhancement
17.5.4. Investment & Funding
17.5.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Baebies, Inc.
18.2. Bio-Rad Laboratories
18.3. Covidien PLC
18.4. Danaher Corporation
18.5. Demant A/S
18.6. GE Healthcare
18.7. Medtronic Plc
18.8. MP BIOMEDICALS
18.9. Natus Medical Incorporated
18.10. PerkinElmer, Inc.
18.11. Thermo Fisher Scientific Inc.
18.12. Trivitron Healthcare

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES NEWBORN SCREENING MARKET: RESEARCH PROCESS
FIGURE 2. UNITED STATES NEWBORN SCREENING MARKET SIZE, 2022 VS 2030
FIGURE 3. UNITED STATES NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 5. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 7. UNITED STATES NEWBORN SCREENING MARKET DYNAMICS
FIGURE 8. UNITED STATES NEWBORN SCREENING MARKET PORTER'S FIVE FORCES ANALYSIS
FIGURE 9. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 10. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 12. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
FIGURE 13. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
FIGURE 14. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2022 VS 2030 (%)
FIGURE 15. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY TEST TYPE, 2030
FIGURE 17. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CCHD, 2018-2030 (USD MILLION)
FIGURE 18. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, 2018-2030 (USD MILLION)
FIGURE 19. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HEARING SCREENING, 2018-2030 (USD MILLION)
FIGURE 20. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2030 (%)
FIGURE 21. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 22. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY TECHNOLOGY, 2030
FIGURE 23. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY ENZYME ASSAY, 2018-2030 (USD MILLION)
FIGURE 24. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
FIGURE 25. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
FIGURE 26. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PULSE OXIMETRY, 2018-2030 (USD MILLION)
FIGURE 27. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, 2018-2030 (USD MILLION)
FIGURE 28. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 29. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 30. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 31. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
FIGURE 32. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
FIGURE 33. CALIFORNIA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 34. FLORIDA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 35. ILLINOIS NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 36. NEW YORK NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 37. OHIO NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 38. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 39. TEXAS NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 40. UNITED STATES NEWBORN SCREENING MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 41. UNITED STATES NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 42. UNITED STATES NEWBORN SCREENING MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022

List of Tables

TABLE 1. UNITED STATES NEWBORN SCREENING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. UNITED STATES NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 5. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 6. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
TABLE 7. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CONSUMABLES, BY STATE, 2018-2030 (USD MILLION)
TABLE 8. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD MILLION)
TABLE 9. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY INSTRUMENT, BY STATE, 2018-2030 (USD MILLION)
TABLE 10. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 11. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CCHD, 2018-2030 (USD MILLION)
TABLE 12. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CCHD, BY STATE, 2018-2030 (USD MILLION)
TABLE 13. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, 2018-2030 (USD MILLION)
TABLE 14. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY DRIED BLOOD SPOT, BY STATE, 2018-2030 (USD MILLION)
TABLE 15. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HEARING SCREENING, 2018-2030 (USD MILLION)
TABLE 16. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HEARING SCREENING, BY STATE, 2018-2030 (USD MILLION)
TABLE 17. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 18. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY ENZYME ASSAY, 2018-2030 (USD MILLION)
TABLE 19. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY ENZYME ASSAY, BY STATE, 2018-2030 (USD MILLION)
TABLE 20. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, 2018-2030 (USD MILLION)
TABLE 21. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY IMMUNOASSAY, BY STATE, 2018-2030 (USD MILLION)
TABLE 22. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR, 2018-2030 (USD MILLION)
TABLE 23. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY MOLECULAR, BY STATE, 2018-2030 (USD MILLION)
TABLE 24. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PULSE OXIMETRY, 2018-2030 (USD MILLION)
TABLE 25. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY PULSE OXIMETRY, BY STATE, 2018-2030 (USD MILLION)
TABLE 26. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, 2018-2030 (USD MILLION)
TABLE 27. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY TANDEM MASS SPECTROMETRY, BY STATE, 2018-2030 (USD MILLION)
TABLE 28. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 29. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CLINICAL LABORATORIES, 2018-2030 (USD MILLION)
TABLE 30. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY CLINICAL LABORATORIES, BY STATE, 2018-2030 (USD MILLION)
TABLE 31. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 32. UNITED STATES NEWBORN SCREENING MARKET SIZE, BY HOSPITALS, BY STATE, 2018-2030 (USD MILLION)
TABLE 33. CALIFORNIA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 34. CALIFORNIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 35. CALIFORNIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 36. CALIFORNIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. CALIFORNIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 38. FLORIDA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 39. FLORIDA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 40. FLORIDA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 41. FLORIDA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. FLORIDA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 43. ILLINOIS NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 44. ILLINOIS NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ILLINOIS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. ILLINOIS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ILLINOIS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. NEW YORK NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 49. NEW YORK NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 50. NEW YORK NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 51. NEW YORK NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. NEW YORK NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 53. OHIO NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 54. OHIO NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 55. OHIO NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 56. OHIO NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. OHIO NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 58. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 59. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 60. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 61. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 62. PENNSYLVANIA NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. TEXAS NEWBORN SCREENING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 64. TEXAS NEWBORN SCREENING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 65. TEXAS NEWBORN SCREENING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 66. TEXAS NEWBORN SCREENING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. TEXAS NEWBORN SCREENING MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES NEWBORN SCREENING MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 69. UNITED STATES NEWBORN SCREENING MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 70. UNITED STATES NEWBORN SCREENING MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 71. UNITED STATES NEWBORN SCREENING MARKET RANKING, BY KEY PLAYER, 2022
TABLE 72. UNITED STATES NEWBORN SCREENING MARKET SHARE, BY KEY PLAYER, 2022
TABLE 73. UNITED STATES NEWBORN SCREENING MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 74. UNITED STATES NEWBORN SCREENING MARKET MERGER & ACQUISITION
TABLE 75. UNITED STATES NEWBORN SCREENING MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 76. UNITED STATES NEWBORN SCREENING MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 77. UNITED STATES NEWBORN SCREENING MARKET INVESTMENT & FUNDING
TABLE 78. UNITED STATES NEWBORN SCREENING MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 79. UNITED STATES NEWBORN SCREENING MARKET: LICENSE & PRICING

Companies Mentioned

Baebies, Inc.
Bio-Rad Laboratories
Covidien PLC
Danaher Corporation
Demant A/S
GE Healthcare
Medtronic Plc
MP BIOMEDICALS
Natus Medical Incorporated
PerkinElmer, Inc.
Thermo Fisher Scientific Inc.
Trivitron Healthcare

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.